AIIMS Delhi signed a memorandum of understanding on Thursday with 19 other AIIMS institutions to promote joint research in areas like artificial intelligence in healthcare and low-cost cancer treatments. This agreement creates a pan-India research consortium of 20 AIIMS institutes. Officials say the group will focus on multicentric clinical trials and key health challenges facing the country.

AIによるレポート

As antibiotics increasingly fail, researchers at AIIMS Delhi are leading the battle against superbugs through early diagnosis, biomarker research, and rational antibiotic use. A recent case of a 50-year-old man with resistant bacterial meningitis underscores the urgency. The institute is running multiple projects to slow down antimicrobial resistance.

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否